Renal manifestations of hepatitis C virus infection (Q40591268)

21 September 2017

1 reference

title

Renal manifestations of hepatitis C virus infection (English)

1 reference

21 September 2017

1 reference

Johnson RJ

1

1 reference

21 September 2017

Willson R

2

1 reference

21 September 2017

Yamabe H

3

1 reference

21 September 2017

Couser W

4

1 reference

21 September 2017

Alpers CE

5

1 reference

21 September 2017

Wener MH

6

1 reference

21 September 2017

Davis C

7

1 reference

21 September 2017

Gretch DR

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

21 September 2017

1 reference

21 September 2017

46

1 reference

21 September 2017

5

1 reference

21 September 2017

1255-1263

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1994.393

21 September 2017

0 references

cites work

A "NEW" ANTIGEN IN LEUKEMIA SERA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Immunologic distinction between infectious and serum hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Detection of Hepatitis C Virus Antibody in the Absence of Viral RNA in Patients with Autoimmune Hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Seroprevalence of hepatitis C antibody in Peru

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus in patients with cryoglobulinemia type II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Antibodies against hepatitis C virus in mixed cryoglobulinemia patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cryoglobulinaemia and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cryoglobulinaemia and hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus and mixed cryoglobulinaemias

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C: a possible etiology for cryoglobulinaemia type II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

A role for hepatitis C virus infection in type II cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cryoglobulinemia with vasculitis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Mixed cryoglobulinemia and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Membranoproliferative glomerulonephritis and hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Membranoproliferative glomerulonephritis and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C infection and membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Mooren's corneal ulcers and hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Polyarteritis nodosa and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Association between hepatitis B virus and essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Renal involvement in essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

The kidney in mixed cryoglobulinemias

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Renal involvement in essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cell interposition in glomerular capillary walls in cryoglobulinemic glomerulonephritis (CRYGN). Ultrastructural investigation of 23 cases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

The membranous and proliferative glomerulonephritis of hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Immune-complex disease of the kidney associated with chronic hepatitis and cryoglobulinaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Acute Glomerulonephritis Complicating Australia Antigen-Negative Viral Hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cirrhotic glomerulonephritis: incidence, morphology, clinical features, and pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Universal occurrence of glomerular abnormalities in patients receiving liver transplants

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Glomerulonephritis with end-stage liver disease in childhood

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Epidemiology of idiopathic glomerular disease: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Variations of primary glomerulonephritis incidence in a rural area of 400,000 inhabitants in the last decade

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Is membranoproliferative glomerulonephritis really decreasing? A multicentre study of 1,548 cases of primary glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus infection and membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Membranous glomerulonephritis in association with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Therapeutic approaches in mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Cross-idiotypic specificity among monoclonal IgM proteins with anti- -globulin activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Determinants of immune complex-mediated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Demonstration of Immune Complexes in Spontaneous and Histamine-Induced Lesions and in Normal Skin of Patients with Leukocytoclastic Angiitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Anti-GOR and hepatitis C virus in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Treatment of idiopathic mixed cryoglobulinemia with alpha interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Mixed cryoglobulinemia responsive to interferon-alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Alpha interferon in the treatment of mixed cryoglobulinaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Low-dose interferon-alpha for mixed cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Mechanisms of action of interferons

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Nephrotic syndrome during treatment with interferon

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Infectious complications of cyclophosphamide treatment for vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C viral infection in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

The impact of hepatitis C virus infection on renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.393

7 January 2021

Identifiers

DOI

10.1038/KI.1994.393

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference